Fertility and Sterility
Volume 95, Issue 1 , Pages 330-332 , January 2011

Day 2 versus day 3 embryo transfer in poor responders: a prospective randomized trial

Received 17 September 2009 ,Revised 24 June 2010 ,Accepted 26 June 2010.

References 

  1. Surrey ES, Schoolcraft WB. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril. 2000;73:667–676
  2. Jenkins JM, Davies DW, Davonport H, Antony FW, Gadd SC, Watson RH, et al. Comparison of “poor” responders with “good” responders using a standard buserelin/human menopausal gonadotropin regime for in-vitro fertilization. Hum Reprod. 1991;6:918–921
  3. Ben-Rafael Z, Bider D, Dan U, Zolti M, Levran D, Mashiach S. Combined gonadotropin releasing homone agonist/human menopausal gonadotropin therapy (GnRH-a/hMG) in normal, high, and poor responders to hMG. J In Vitro Fert Embryo Transf. 1991;8:33–36
  4. Kyrou D, Kolibianakis EM, Venetis CA, Papanikolaou EG, Bontis J, Tarlatzis BC. How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Fertil Steril. 2009;91:749–766
  5. Shen S, Rosen MP, Dobson AT, Fujimoto VY, McCulloch CE, Cedars MI. Day 2 transfer improves pregnancy outcome in in vitro fertilization cycles with few available embryos. Fertil Steril. 2006;86:44–50
  6. Bahceci M, Ulug U, Ciray N, Akman MA, Erden HF. Efficiency of changing the embryo transfer time from day 3 to day 2 among women with poor ovarian response: a prospective randomized trial. Fertil Steril. 2006;86:81–85
  7. Jun SH, Choi B, Shahine L, Westphal LM, Behr B, Reijo Pera RA, et al. Defining human embryo phenotypes by cohort-specific prognostic factors. PLoS ONE. 2008;3:e2562
  8. Dragisic KG, Davis OK, Fasouliotis SJ, Rosenwaks Z. Use of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation for in vitro fertilization in poor responders. Fertil Steril. 2005;84:1023–1026
  9. Shahine LK, Lathi RB, Baker VB. Oocyte retrieval versus conversion to intrauterine insemination in patients with poor response to gonadotropin therapy. Fertil Steril. Published online April 24, 2009.
  10. Toner JP, Brzyski RG, Oehninger S, Veeck LL, Simonetti S, Muasher SJ. Combined impact of the number of pre-ovulatory oocytes and cryopreservation on IVF outcome. Hum Reprod. 1991;6:284–289
  11. Gunby JL, Daya S, Olive D, Brown J. Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection. Cochrane Database Syst Rev. 2004;(2):CD004378

 L.K.S. has nothing to disclose. A.A.M. has nothing to disclose. L.M.W. has nothing to disclose. V.L.B. has nothing to disclose. B.B. has nothing to disclose. R.B.L. has nothing to disclose.

PII: S0015-0282(10)01048-4

doi: 10.1016/j.fertnstert.2010.06.093

Fertility and Sterility
Volume 95, Issue 1 , Pages 330-332 , January 2011

Article Tools